http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005053940-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 |
| filingDate | 2002-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0dd303cc829d66cb9e9a1c82bdbecc4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8860a605d6c053849443f192d13b1d96 |
| publicationDate | 2005-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2005053940-A1 |
| titleOfInvention | Huntington's disease gene transcriptional factors |
| abstract | The present invention provides an isolated and purified transcriptional factors for the Huntington's disease gene, which have the amino acid sequence of SEQ ID No. 2 or SEQ ID No. 4 as a protein factor associated with the transcription of the Huntington's disease gene product. The invention also provides a polynucleotides encoding such transcriptional factors. These inventions are useful in the development of a therapeutic technology for an artificial control of the production of a pathogenically mutated huntingtin in HD, or in the development of a therapeutic method or agent against a selective neuronal cell death in HD. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9169482-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013065281-A1 |
| priorityDate | 2001-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.